Aquestive Therapeutics, Inc. (AQST) — Revenue

Annual figures by fiscal year, from SEC filings.

2018: $67.43M2019: $52.61M2020: $45.85M2021: $50.83M2022: $47.68M2023: $50.58M2024: $57.56M2025: $44.55M$44.55M
2018Revenue (USD)2025
Fiscal YearRevenueChange YoY
2025$44.55M-22.6%
2024$57.56M+13.8%
2023$50.58M+6.1%
2022$47.68M-6.2%
2021$50.83M+10.9%
2020$45.85M-12.8%
2019$52.61M-22.0%
2018$67.43M